Oral [spco]
Vasodilators [phsu]
Primary [qlco]
Raynaud Phenomenon [dsyn]
Background [cnce]
Different [qlco]
Drugs [phsu]
Suggest [idcn]
Symptomatic [ftcn]
treatment [ftcn]
Primary [qlco]
Raynaud Phenomenon [dsyn]
Calcium Channel Blockers [phsu]
considered [idcn]
Drugs [phsu]
choice [inbe]
Evidence [ftcn]
effects [qlco]
Alternative [cnce]
Pharmacological Treatments [topp]
Limited [ftcn]
This [euka]
Update [tmco]
Review [inpr]
First [qnco]
Published [ocac]
objectives [inpr]
To [qlco]
Assess [acty]
effects [qlco]
Various [irda]
Drugs [phsu]
Vasodilator [phsu]
actions [ftcn]
Primary [qlco]
Raynaud Phenomenon [dsyn]
search [inpr]
Methods [inpr]
Update [tmco]
Peripheral Vascular Diseases [dsyn]
Group [idcn]
Trial [resa]
search [inpr]
Searched [acty]
specialised [qlco]
Last [qlco]
Searched [acty]
Central [spco]
Issue [fndg]
Clinical Trials Database [inpr]
contact [ftcn]
One [qnco]
Pharmaceutical Company [hcro]
One [qnco]
Trial [resa]
Author [prog]
Additional information [tmco]
Addition [ftcn]
Reference [idcn]
List [cnce]
Relevant [qlco]
studies [lbpr]
Searched [acty]
Additional [ftcn]
citations [inpr]
Language [lang]
Restriction [ftcn]
Selection Criteria [qlco]
Controlled [ftcn]
Trial [resa]
Evaluate [ftcn]
effects [qlco]
Oral [spco]
Formulation [resa]
Drug [phsu]
Vasodilator [phsu]
effects [qlco]
Subjective [qlco]
symptoms [ftcn]
Primary [qlco]
Raynaud Phenomenon [dsyn]
treatment [ftcn]
Comparison [acty]
Calcium Channel Blockers [phsu]
Not [ftcn]
Assessed [acty]
Review [inpr]
Data Collection [resa]
Analysis [lbpr]
Two [qnco]
Review [inpr]
Team [grup]
Assessed [acty]
Trial [resa]
Inclusion [qlco]
Quality [qlco]
Extracted [topp]
Data [idcn]
Data Extraction [resa]
included [ftcn]
adverse events [fndg]
contact [ftcn]
Trial [resa]
Authors [prog]
Missing [idcn]
Data [idcn]
Main [qlco]
Result [ftcn]
Eight [qnco]
studies [lbpr]
Involving [ftcn]
participants [popg]
included [ftcn]
Two [qnco]
Trial [resa]
Examined [fndg]
effects [qlco]
Captopril [aapp, phsu]
Rest [dora]
Single [popg]
Trial [resa]
Single [popg]
Drugs [phsu]
Comparison [acty]
placebo [topp]
methodology [inpr]
Quality [qlco]
Trial [resa]
Poor [grpa]
Enalapril [aapp, phsu]
Associated [qlco]
Small [qnco]
Increase [ftcn]
frequency [qnco]
attacks [socb]
Means [cnce]
intervention [hlca]
Group [idcn]
Subjective Improvement [cnce]
Score [qnco]
Non [ftcn]
Effect [qlco]
buflomedil [orch, phsu]
frequency [qnco]
attacks [socb]
weighted [orga]
Mean [qnco]
Evidence [ftcn]
Effect [qlco]
Severity score [qnco]
Proportion [qnco]
Few [qnco]
attacks [socb]
High [qlco]
Moxisylyte [orch, phsu]
placebo [topp]
Relative Risk [qnco]
Captopril [aapp, phsu]
beraprost [eico, horm, phsu]
dazoxiben [orch, phsu]
Ketanserin [orch, phsu]
Evidence [ftcn]
Effect [qlco]
frequency [qnco]
Severity [qlco]
Duration [tmco]
attacks [socb]
beraprost [eico, horm, phsu]
Moxisylyte [orch, phsu]
Give [ftcn]
adverse effects [ftcn]
placebo [topp]
Authors [prog]
Conclusions [idcn]
Poor [grpa]
methodology [inpr]
Quality [qlco]
Small [qnco]
Sizes, Sample [qnco]
Limited [ftcn]
Data [idcn]
Available [ftcn]
Result [ftcn]
low [qlco]
Precision [tmco]
Statistical [ocdi]
Result [ftcn]
Limited [ftcn]
Value [qnco]
Overall [inpr]
Result [ftcn]
Overall [inpr]
Result [ftcn]
Show [inpr]
Evidence [ftcn]
Effect [qlco]
Vasodilator Drugs [phsu]
Primary [qlco]
Raynaud Phenomenon [dsyn]
